Sale of Securities

Rapport Therapeutics, Inc. Filed 2026-04-17 Acc 0001950047-26-003609

Documents 1

2026-04-21 4 10% owner sold 426,005 shares at $40.32 ($17,175,244)
2026-04-21 4 Chief Development Officer sold 20,225 shares at $39.99 ($808,844)
2026-04-21 8-K Regulation FD disclosure · Other events
2026-04-17 144 Sale of Securities
2026-04-17 144 Sale of Securities
2026-04-14 4 Chief Development Officer sold 19,865 shares at an average $35.03 ($695,823)
2026-04-13 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…